Eledon Pharmaceuticals (ELDN) Shareholder's Equity (2013 - 2026)

Eledon Pharmaceuticals (ELDN) Shareholder's Equity (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 7.14 Bn
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 595,226.00
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 14.38 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 19.36 Bn
9 Abivax 90.15 Bn 90.15 Bn - 502.95 Mn
10 Eledon Pharmaceuticals 401.35 Mn 185.32 Mn - 44.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 44.76 Mn
Dec 31, 2025 81.09 Mn
Sep 30, 2025 35.36 Mn
Jun 30, 2025 50.33 Mn
Mar 31, 2025 58.89 Mn
Dec 31, 2024 62.45 Mn
Sep 30, 2024 20.36 Mn
Jun 30, 2024 -64.20 Mn
Mar 31, 2024 -70.42 Mn
Dec 31, 2023 -48.49 Mn
Sep 30, 2023 35.60 Mn
Jun 30, 2023 43.77 Mn
Mar 31, 2023 74.79 Mn
Dec 31, 2022 23.79 Mn
Sep 30, 2022 141.09 Mn
Jun 30, 2022 149.38 Mn
Mar 31, 2022 156.32 Mn
Dec 31, 2021 164.00 Mn
Sep 30, 2021 170.75 Mn
Jun 30, 2021 178.52 Mn